Skip to main content
Premium Trial:

Request an Annual Quote

Christopher Becker, William Leschensky, and Francis Lunger


Christopher Becker has been promoted to the position of vice president, chemistry, for SurroMed.

Becker joined SurroMed in 2001 as director of chemistry. Prior to this, he was senior director of proteomic technology at Thermo Electron, and earlier, a staff scientist with SRI International. He conducted his postdoctoral work in chemistry and physics at Massachusetts Institute of Technology, and received his PhD in chemistry from University of California, Berkeley.

SurroMed has also promoted William Leschensky to the position of vice president of intellectual property. He joined the company in 2000 as director of intellectual property and has served as associate general counsel. Prior to this, he was an associate at the law firm of Fish & Neave. He received his MD from the University of Illinois and a law degree from Harvard Law School.

Millipore has announced that Francis Lunger, chairman of the board, president, and CEO, has decided to step down as president and CEO upon the naming of his replacement before March 1, 2005. Lunger will continue to remain chairman of the board for a period of time after his successor is named.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.